An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Investigational Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to message these accounts directly for source information, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and assertions of rapid British shipping. Vendors market the substance there before directing buyers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting products of unknown origin.
Some professionals stated the demand for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the British medical regulations.
Some influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, advertising, and consumer laws, risking penalties, legal action or imprisonment.
Platform Response and Content Removal
Based on the social media company, the service has taken down problematic material and prohibited associated hashtags and query recommendations. The organization said it was committed to keeping the service safe and investing in strengthening compliance measures.
Digital Trading Operations
Investigations also found groups with up to 9,000 participants marketing retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, populated with photos of slimming results, positive testimonials and step-by-step instructions for preparing or administering at residence.
After moments of joining one community, a seller shared contact information, where most purchases occur. The vendor sent an guidebook and guaranteed shipping within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about weight, health issues or past usage.
Item Details and Costs
Within these groups, posts show dark colored packages with Royal Mail labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how long a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Platform Oversight and Security Measures
A spokesperson for the messaging service said it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting materials they can’t verify. Although the science behind this drug is valid, these digital versions may not include what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the surge in interest to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has previously seen patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational product not yet authorized … may subject users to potentially serious health risks”.
